| 查看: 1205 | 回复: 1 | ||
| 本帖产生 1 个 翻译EPI ，点击这里进行查看 | ||
csu03712木虫 (著名写手)
|
[求助]
求助翻译一段英文文献（高分子聚合方向）
|
|
|
也可以翻译其中一段，谢谢！ Bacterial drug resistance has become a serious problem in hospitals and community environments, as currently used treatments with broad-spectrum antibiotics are becoming progressively less effective.1 One of the most dangerous human pathogens in this regard is methicillin-resistant Staphylococcus aureus (MRSA), an opportunistic microbe commonly found in skin abrasions and open wounds. Without treatment, these drug-resistant infections can lead rapidly to the onset of bacteremia, sepsis, and toxic shock syndrome.2-4 Drug-resistant infections claim thousands of lives annually in the United States, and antibiotic therapy has been reduced to only a few approved therapies. This problem will most certainly continue to escalate as antibiotic resistance becomes even more widespread and serious. In addition to issues relating to acquired antibiotic resistance, many antibiotics are generally less effective in treating infections in fatty tissue, biofilms, or along the surfaces of bone and artificial devices where drug-resistant bacterial infections are so often found.9 Some lipophilic antimicrobials are also limited to topical application because of their low water solubility for systemic administration. Our laboratory has become interested in exploring the use of nanoparticle-based antibiotics as potential treatments for life-threatening bacterial infections. One obvious use of the nanoparticles would be for enhancing performance of antibacterial drugs that otherwise suffers from poor water solubility, stability, toxicity, or pharmacokinetics and distribution. Many lipid, phospholipid, and triglyceride-based emulsions containing droplets at the submicron level have shown benefits when used for drug delivery, including delivering the dissolved drug solely to its intended destination in the body, providing the drug with controlled release, increasing the uptake and efficiency of the drug, and also reducing the inherent toxicity of the drug monomer, as in the case of amphotericin B.11-18 More recently, nanoparticles made from metals, fullerenes, synthetic and natural polymers, and various lipids have been investigated for certain drug delivery applications,19-25 a process wrought with questions and concerns relating to their ultimate benefits, applications, and potential drawbacks. One of the major concerns with the use of nanomaterials is the heightened risk of toxicity due to their extremely small size, their physical properties, their unknown chemical and biochemical interactions, as well as their ease of penetration through cellular and blood-brain barriers. Toxicological analysis of metal-based nanoparticles in solution has been underway for some time,20,22,24; however, evaluation of new nanoparticle materials for cytotoxic or systemic toxicity has not kept up with the rapid evolution of the nanotechnology field. Polyacrylates have been used since the 1960s as biomedical coatings on devices and surgical glues, and are considered nontoxic26-35; moreover, emulsified polyacrylates, likewise, have been studied as colloidal drug carriers.11-18,28,36-41 However, data on toxicity and biocompatibility of polyacrylate nanoparticles (having diameters b100 nm) is severely lacking. |
回复此楼» 猜你喜欢
有多少人是今天查系统知道结果的？
已经有17人回复
-
基金不中，共勉
已经有4人回复
-
国自然面上复盘~欢迎讨论
已经有5人回复
-
我不理解！
已经有23人回复
-
2026年的国家社科基金项目通讯评审的新规则与新动向、新挑战
已经有10人回复
-
系统查不到
已经有10人回复
-
怎么查啊
已经有5人回复
-
范进中举一文的中心思想
已经有10人回复
-
2026国自然函评费到账
已经有25人回复
-
2026年8月25日国自然放榜前突然收到列入评审专家邮件，有关系吗？
已经有28人回复
2楼2011-05-11 12:05:48
